Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Sebastian Zeissig - , Chair of Mucosal Immunology, Department of Internal Medicine I, Center for Regenerative Therapies Dresden (Author)
Elisa Rosati - (Author)
C. Marie Dowds - (Author)
Konrad Aden - (Author)
Johannes Bethge - (Author)
Berenice Schulte - (Author)
Wei Hung Pan - (Author)
Neha Mishra - (Author)
Maaz Zuhayra - (Author)
Marlies Marx - (Author)
Maren Paulsen - (Author)
Anne Strigli - , Chair of Mucosal Immunology, Center for Regenerative Therapies Dresden (Author)
Claudio Conrad - (Author)
Doerthe Schuldt - (Author)
Anupam Sinha - , Institute of Clinical Chemistry and Laboratory Medicine (Author)
Henriette Ebsen - (Author)
Sabin-Christin Kornell - (Author)
Susanna Nikolaus - (Author)
Alexander Arlt - (Author)
Dieter Kabelitz - (Author)
Mark Ellrichmann - (Author)
Ulf Luetzen - (Author)
Philip C. Rosenstiel - (Author)
Andre Franke - (Author)
Stefan Schreiber - (Author)

WOS	000455727900008
Scopus	85049130085